187 related articles for article (PubMed ID: 16304558)
1. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
[TBL] [Abstract][Full Text] [Related]
2. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
[TBL] [Abstract][Full Text] [Related]
3. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
[TBL] [Abstract][Full Text] [Related]
4. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia].
Wang Z; Lai FM
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203
[TBL] [Abstract][Full Text] [Related]
6. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
[TBL] [Abstract][Full Text] [Related]
7. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer.
Huang Z; Wen Y; Shandilya R; Marks JR; Berchuck A; Murphy SK
Nucleic Acids Res; 2006; 34(2):555-63. PubMed ID: 16432260
[TBL] [Abstract][Full Text] [Related]
8. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495
[TBL] [Abstract][Full Text] [Related]
10. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.
Killian JK; Oka Y; Jang HS; Fu X; Waterland RA; Sohda T; Sakaguchi S; Jirtle RL
Hum Mutat; 2001; 18(1):25-31. PubMed ID: 11438990
[TBL] [Abstract][Full Text] [Related]
11. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
[TBL] [Abstract][Full Text] [Related]
13. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan.
Wada I; Kanada H; Nomura K; Kato Y; Machinami R; Kitagawa T
Hepatology; 1999 Jun; 29(6):1718-21. PubMed ID: 10347113
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma.
Häggman MJ; Wojno KJ; Pearsall CP; Macoska JA
Urology; 1997 Oct; 50(4):643-7. PubMed ID: 9338751
[TBL] [Abstract][Full Text] [Related]
16. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
Mills JJ; Falls JG; De Souza AT; Jirtle RL
Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas.
Strup SE; Pozzatti RO; Florence CD; Emmert-Buck MR; Duray PH; Liotta LA; Bostwick DG; Linehan WM; Vocke CD
J Urol; 1999 Aug; 162(2):590-4. PubMed ID: 10411092
[TBL] [Abstract][Full Text] [Related]
18. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
